ClearPoint Neuro (CLPT) Net Income Growth (5y) (2016 - 2026)
ClearPoint Neuro (CLPT) Net Income Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | ClearPoint Neuro | 428.13 Mn | 392.54 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.62% |
| Dec 31, 2025 | -25.72% |
| Sep 30, 2025 | -1.85% |
| Jun 30, 2025 | -20.03% |
| Mar 31, 2025 | -19.43% |
| Dec 31, 2024 | -23.46% |
| Sep 30, 2024 | -34.65% |
| Jun 30, 2024 | -23.22% |
| Mar 31, 2024 | -26.83% |
| Dec 31, 2023 | -21.26% |
| Sep 30, 2023 | -36.01% |
| Jun 30, 2023 | -42.90% |
| Mar 31, 2023 | -27.59% |
| Sep 30, 2021 | -57.92% |
| Jun 30, 2021 | -51.39% |
| Mar 31, 2021 | -59.79% |
| Sep 30, 2020 | -19.12% |
| Jun 30, 2020 | 4.76% |
| Mar 31, 2020 | 5.24% |
| Dec 31, 2019 | 11.14% |